QQQ   290.27 (-2.02%)
AAPL   143.00 (-2.01%)
MSFT   242.71 (-2.20%)
META   147.06 (-3.08%)
GOOGL   96.94 (-2.45%)
AMZN   100.55 (-1.65%)
TSLA   166.66 (-6.32%)
NVDA   191.62 (-5.91%)
NIO   12.02 (-5.43%)
BABA   111.20 (-6.07%)
AMD   72.45 (-3.91%)
T   20.16 (+1.05%)
MU   61.71 (-3.38%)
F   12.89 (-2.86%)
CGC   2.84 (-3.07%)
GE   80.83 (-2.88%)
DIS   107.59 (-1.78%)
AMC   5.01 (-9.07%)
PFE   43.55 (-0.55%)
PYPL   79.64 (-2.68%)
NFLX   353.11 (-2.12%)
QQQ   290.27 (-2.02%)
AAPL   143.00 (-2.01%)
MSFT   242.71 (-2.20%)
META   147.06 (-3.08%)
GOOGL   96.94 (-2.45%)
AMZN   100.55 (-1.65%)
TSLA   166.66 (-6.32%)
NVDA   191.62 (-5.91%)
NIO   12.02 (-5.43%)
BABA   111.20 (-6.07%)
AMD   72.45 (-3.91%)
T   20.16 (+1.05%)
MU   61.71 (-3.38%)
F   12.89 (-2.86%)
CGC   2.84 (-3.07%)
GE   80.83 (-2.88%)
DIS   107.59 (-1.78%)
AMC   5.01 (-9.07%)
PFE   43.55 (-0.55%)
PYPL   79.64 (-2.68%)
NFLX   353.11 (-2.12%)
QQQ   290.27 (-2.02%)
AAPL   143.00 (-2.01%)
MSFT   242.71 (-2.20%)
META   147.06 (-3.08%)
GOOGL   96.94 (-2.45%)
AMZN   100.55 (-1.65%)
TSLA   166.66 (-6.32%)
NVDA   191.62 (-5.91%)
NIO   12.02 (-5.43%)
BABA   111.20 (-6.07%)
AMD   72.45 (-3.91%)
T   20.16 (+1.05%)
MU   61.71 (-3.38%)
F   12.89 (-2.86%)
CGC   2.84 (-3.07%)
GE   80.83 (-2.88%)
DIS   107.59 (-1.78%)
AMC   5.01 (-9.07%)
PFE   43.55 (-0.55%)
PYPL   79.64 (-2.68%)
NFLX   353.11 (-2.12%)
QQQ   290.27 (-2.02%)
AAPL   143.00 (-2.01%)
MSFT   242.71 (-2.20%)
META   147.06 (-3.08%)
GOOGL   96.94 (-2.45%)
AMZN   100.55 (-1.65%)
TSLA   166.66 (-6.32%)
NVDA   191.62 (-5.91%)
NIO   12.02 (-5.43%)
BABA   111.20 (-6.07%)
AMD   72.45 (-3.91%)
T   20.16 (+1.05%)
MU   61.71 (-3.38%)
F   12.89 (-2.86%)
CGC   2.84 (-3.07%)
GE   80.83 (-2.88%)
DIS   107.59 (-1.78%)
AMC   5.01 (-9.07%)
PFE   43.55 (-0.55%)
PYPL   79.64 (-2.68%)
NFLX   353.11 (-2.12%)
NASDAQ:OPK

OPKO Health - OPK Stock Forecast, Price & News

$1.23
-0.03 (-2.38%)
(As of 01/30/2023 12:00 AM ET)
Add
Compare
Today's Range
$1.22
$1.27
50-Day Range
$1.05
$1.61
52-Week Range
$1.03
$3.78
Volume
2.00 million shs
Average Volume
2.59 million shs
Market Capitalization
$950.40 million
P/E Ratio
N/A
Dividend Yield
N/A
Price Target
$3.50

OPKO Health MarketRank™ Forecast

Analyst Rating
Buy
3.00 Rating Score
Upside/​Downside
184.6% Upside
$3.50 Price Target
Short Interest
Bearish
9.06% of Float Sold Short
Dividend Strength
N/A
Sustainability
-1.65
Upright™ Environmental Score
News Sentiment
0.64mentions of OPKO Health in the last 14 days
Based on 4 Articles This Week
Insider Trading
Acquiring Shares
$767,000 Bought Last Quarter
Proj. Earnings Growth
Growing
From ($0.43) to ($0.33) Per Share

Overall MarketRank

MarketRank is calculated as an average of available category scores, with extra weight given to analysis and valuation.

2.49 out of 5 stars

Medical Sector

166th out of 1,049 stocks

Pharmaceutical Preparations Industry

77th out of 514 stocks


OPK stock logo

About OPKO Health (NASDAQ:OPK) Stock

OPKO Health, Inc. is a biopharmaceutical and diagnostics company, which engages in the provision of healthcare services. It operates through the following segments: Diagnostics and Pharmaceuticals. The Diagnostics segment includes the clinical laboratory operations of BioReference, as well as point-of-care operations. The Pharmaceuticals segment includes pharmaceutical operations in Chile, Mexico, Ireland, Israel, and Spain and pharmaceutical research and development operations. The company was founded in October 1991 and is headquartered in Miami, FL.

Receive OPK Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for OPKO Health and its competitors with MarketBeat's FREE daily newsletter.

OPK Stock News Headlines

OPKO Health (NASDAQ:OPK) Shares Gap Down to $1.49
Profit From the Commercial Solar Boom?
Solar energy had its best year ever in 2021, with a record 24 gigawatts of power installed. That's enough to power 18 million homes! Analysts expect the global solar farm market to reach $356 billion by 2028. The utility segment of the solar market is expected to grow at the highest annual growth rate in the industry, especially with the many tax incentives now offered.
"We need batteries. Literally everywhere."
Pretty much every technological megatrend today requires batteries. That includes EVs... 5G... AI... charging stations... and smart energy storage systems. Find out why the U.S. just added graphite to a list of super-critical minerals, calling it "essential for America's National Defense."
No Cure For OPKO Health, Inc.
OPKO Health (OPK) Q3 Earnings Lag Estimates, Revenues Top
See More Headlines
Receive OPK Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for OPKO Health and its competitors with MarketBeat's FREE daily newsletter.

OPK Company Calendar

Last Earnings
11/08/2022
Today
1/30/2023
Next Earnings (Estimated)
2/23/2023
Fiscal Year End
12/31/2023

Industry, Sector and Symbol

Industry
Pharmaceutical preparations
Sub-Industry
Biotechnology
Sector
Medical
Current Symbol
NASDAQ:OPK
CUSIP
68375N10
Employees
5,767
Year Founded
N/A

Price Target and Rating

Average Stock Price Forecast
$3.50
High Stock Price Forecast
$4.00
Low Stock Price Forecast
$3.00
Forecasted Upside/Downside
+184.6%
Consensus Rating
Buy
Rating Score (0-4)
3.00
Research Coverage
2 Analysts

Profitability

Net Income
$-30,140,000.00
Pretax Margin
-29.11%

Debt

Sales & Book Value

Annual Sales
$1.22 billion
Cash Flow
$0.07 per share
Book Value
$2.47 per share

Miscellaneous

Free Float
456,117,000
Market Cap
$950.40 million
Optionable
Optionable
Beta
1.65

Key Executives

  • Phillip Frost
    Chairman & Chief Executive Officer
  • Elias A. Zerhouni
    Vice Chairman & President
  • Adam E. Logal
    CFO, Treasurer, Chief Accounting Officer & SVP
  • Jane H. Hsaio
    Vice Chairman & Chief Technical Officer
  • Steven D. Rubin
    Director & Executive Vice President-Administration













OPK Stock - Frequently Asked Questions

Should I buy or sell OPKO Health stock right now?

2 Wall Street equities research analysts have issued "buy," "hold," and "sell" ratings for OPKO Health in the last year. There are currently 2 buy ratings for the stock. The consensus among Wall Street equities research analysts is that investors should "buy" OPK shares.
View OPK analyst ratings
or view top-rated stocks.

What is OPKO Health's stock price forecast for 2023?

2 Wall Street analysts have issued twelve-month target prices for OPKO Health's stock. Their OPK share price forecasts range from $3.00 to $4.00. On average, they expect the company's share price to reach $3.50 in the next year. This suggests a possible upside of 182.3% from the stock's current price.
View analysts price targets for OPK
or view top-rated stocks among Wall Street analysts.

How have OPK shares performed in 2023?

OPKO Health's stock was trading at $1.25 on January 1st, 2023. Since then, OPK shares have decreased by 0.8% and is now trading at $1.24.
View the best growth stocks for 2023 here
.

When is OPKO Health's next earnings date?

The company is scheduled to release its next quarterly earnings announcement on Thursday, February 23rd 2023.
View our OPK earnings forecast
.

How were OPKO Health's earnings last quarter?

OPKO Health, Inc. (NASDAQ:OPK) posted its earnings results on Tuesday, November, 8th. The biotechnology company reported ($0.11) EPS for the quarter, missing analysts' consensus estimates of ($0.10) by $0.01. The biotechnology company had revenue of $179.70 million for the quarter, compared to analyst estimates of $172.68 million. OPKO Health had a negative net margin of 25.98% and a negative trailing twelve-month return on equity of 14.79%.

What is Philip Frost's approval rating as OPKO Health's CEO?

21 employees have rated OPKO Health Chief Executive Officer Philip Frost on Glassdoor.com. Philip Frost has an approval rating of 16% among the company's employees. This puts Philip Frost in the bottom 10% of approval ratings compared to other CEOs of publicly-traded companies.

What other stocks do shareholders of OPKO Health own?

Based on aggregate information from My MarketBeat watchlists, some companies that other OPKO Health investors own include TherapeuticsMD (TXMD), Micron Technology (MU), NVIDIA (NVDA), bluebird bio (BLUE), Gilead Sciences (GILD), Pfizer (PFE), Inovio Pharmaceuticals (INO), Novavax (NVAX), Advanced Micro Devices (AMD) and AT&T (T).

What is OPKO Health's stock symbol?

OPKO Health trades on the NASDAQ under the ticker symbol "OPK."

Who are OPKO Health's major shareholders?

OPKO Health's stock is owned by many different retail and institutional investors. Top institutional investors include Hennion & Walsh Asset Management Inc. (0.07%), Sequoia Financial Advisors LLC (0.01%), Norris Perne & French LLP MI (0.01%), Transcend Capital Advisors LLC (0.01%), Shufro Rose & Co. LLC (0.00%) and RK Asset Management LLC (0.00%). Insiders that own company stock include Anthony J Japour, Elias A Zerhouni, Gary J Nabel, Jon R Cohen, Phillip Md Et Al Frost, Robert J Shovlin and Steven D Rubin.
View institutional ownership trends
.

How do I buy shares of OPKO Health?

Shares of OPK stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include WeBull, Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab.
Compare Top Brokerages Here.

What is OPKO Health's stock price today?

One share of OPK stock can currently be purchased for approximately $1.24.

How much money does OPKO Health make?

OPKO Health (NASDAQ:OPK) has a market capitalization of $958.13 million and generates $1.22 billion in revenue each year. The biotechnology company earns $-30,140,000.00 in net income (profit) each year or ($0.44) on an earnings per share basis.

How many employees does OPKO Health have?

The company employs 5,767 workers across the globe.

How can I contact OPKO Health?

OPKO Health's mailing address is 4400 BISCAYNE BLVD., MIAMI FL, 33137. The official website for the company is www.opko.com. The biotechnology company can be reached via phone at (305) 575-4100, via email at mmiller@lhai.com, or via fax at 305-575-6015.

This page (NASDAQ:OPK) was last updated on 1/30/2023 by MarketBeat.com Staff